In a 49-year-old male with a recent upper respiratory infection who has had persistent hiccups for five days, what are the appropriate treatment options?

Treatment of Persistent Hiccups Following URI

For this 49-year-old male with 5 days of persistent hiccups following a URI, start with chlorpromazine 25-50 mg orally three times daily, as it is the only FDA-approved medication for hiccups and has demonstrated the highest success rate (83%) in recent evidence.

Initial Assessment and Workup

Before initiating treatment, you must exclude serious underlying causes:

• Rule out pneumonia/lung pathology: Obtain a chest X-ray, as multiple recent cases 1, 2, 3, 4 demonstrate that persistent hiccups can be the sole or primary presenting symptom of aspiration pneumonia, lung abscess, or bronchopneumonia—even without typical respiratory symptoms like cough, fever, or dyspnea
• Assess for CNS involvement: Brief neurological examination to exclude brainstem or cerebellar pathology, particularly if any focal neurological signs are present
• Consider metabolic causes: Basic metabolic panel if clinically indicated

The URI context suggests post-infectious irritation of the phrenic nerve or diaphragm, but the absence of typical pneumonia symptoms does not exclude pulmonary pathology 2, 4.

First-Line Pharmacologic Treatment

Chlorpromazine is your primary option:

• Dosing: 25-50 mg orally three times daily 5, 6, 3
• Evidence: Only FDA-approved agent for hiccups 7; demonstrated 83% success rate in COVID-19-associated persistent hiccups 6; successfully used in multiple pneumonia-related hiccup cases 2, 3
• Mechanism: Dopamine antagonist that suppresses the hiccup reflex arc
• Cautions: Monitor for sedation, orthostatic hypotension, extrapyramidal symptoms; use lower doses in elderly

Second-Line Options

If chlorpromazine fails or is contraindicated, consider these alternatives based on the systematic review evidence 7:

Baclofen:

• 5-10 mg three times daily, titrate up to 20 mg three times daily if needed
• Best evidence among alternatives (studied in randomized controlled trials)
• 100% success rate in limited COVID-19 hiccup cases 6
• GABA-B agonist that inhibits reflex arc

Gabapentin:

• 300-400 mg three times daily
• Studied prospectively with favorable outcomes 7
• Modulates calcium channels in reflex pathway

Metoclopramide:

• 10-20 mg orally/IV every 4-6 hours 5
• Important caveat: Despite widespread use, showed 0% success in COVID-19 hiccup cases 6 and has limited supporting evidence
• Consider only if gastroesophageal reflux is suspected as contributing factor 8

Alternative and Adjunctive Therapies

For refractory cases, consider:

• Haloperidol: 0.5-2 mg orally/IV every 4-6 hours 5—another dopamine antagonist with case report success
• Traditional medicine: Hange-koboku-to (HKT) 7.5 g/day in three divided doses showed efficacy when combined with chlorpromazine in one case 3, though this is not widely available
• Interventional approaches: Ultrasound-guided phrenic nerve block combined with percutaneous auricular vagus nerve stimulation showed complete resolution in one recent case 1, but requires specialized expertise

Treatment Duration and Follow-up

• Most cases resolve within 2-5 days of appropriate treatment 6, 3
• Continue medication for 48-72 hours after hiccup resolution, then taper
• If no improvement after 3-5 days of first-line therapy, reassess for underlying causes and consider second-line agents
• Red flags requiring urgent re-evaluation: Development of fever, respiratory symptoms, neurological changes, or worsening despite treatment

Common Pitfalls to Avoid

1. Don't assume benign self-limited course: Persistent hiccups lasting >48 hours warrant investigation, particularly chest imaging, as serious pulmonary pathology can present with hiccups alone 2, 4

2. Don't rely on metoclopramide as first-line: Despite its inclusion in antiemetic guidelines 5, recent evidence shows poor efficacy for persistent hiccups 6

3. Don't overlook post-infectious complications: The URI history suggests upper airway cough syndrome 9 or post-infectious inflammation 8, but secondary bacterial sinusitis or aspiration pneumonia must be excluded

4. Don't use antibiotics empirically: Unless bacterial sinusitis or pneumonia is confirmed, antibiotics have no role 10, 11, 8—the URI is likely viral and antibiotics would be inappropriate

The combination of URI history and 5-day duration suggests post-infectious diaphragmatic or phrenic nerve irritation, making chlorpromazine the most evidence-based initial choice while ensuring serious pulmonary complications are excluded.